Self-sampling of the vaginal fluid at home combined with high-risk HPV testing

被引:80
作者
Sanner, K. [2 ]
Wikstrom, I. [2 ]
Strand, A. [3 ]
Lindell, M. [1 ]
Wilander, E. [1 ]
机构
[1] Univ Uppsala Hosp, Dept Pathol & Cytol, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Women & Childrens Hlth, S-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Dermatovenereol, S-75185 Uppsala, Sweden
关键词
cervix; cytology; screening; HPV test; self-sampling; HUMAN PAPILLOMA-VIRUS; CERVICAL-CANCER; WOMEN; PREVALENCE; SMEAR;
D O I
10.1038/sj.bjc.6605194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Around 65% of women with cervical carcinoma in Sweden have not attended an organised screening. We therefore investigated the value of using self-sampling at home in combination with a test for high-risk human papilloma virus (HPV) to increase participation. METHODS: A total of 2829 women 30-58 years old, who had not attended the organised screening for >= 6 years, were recruited. They were offered self-sampling at home (Qvintip) and recommended to send the collected vaginal fluid to a laboratory for analysis of the presence of high-risk HPV (Hybrid Capture 2 method). RESULTS: A total of 39.1% of the women accepted home sampling. These women disclosed a relatively high prevalence of high-risk HPV, which decreased with age, from 11.1% in women 30-39 years old to 2.9% in women >= 50 years. Follow-up disclosed histological cervical intraepithelial neoplasm (CIN) 2-3 lesions in 43.2% of the women with a persistent HPV infection, corresponding to 2.0% of the total number of participating women. The sensitivity of a single smear to detect the histological CIN 2-3 lesions were only 52.6%, even if all abnormal smears (atypical squamous cells of unknown significance (ASCUS)-CIN 3)) were included. CONCLUSION: The use of self-sampling at home in combination with testing for high-risk HPV increases the participation rate of the organised screening and detects almost twice as many women with pre-malignant cell alterations (CIN 2-3) in comparison those with a single cytological smear. British Journal of Cancer (2009) 101, 871-874. doi:10.1038/sj.bjc.6605194 www.bjcancer.com Published online 4 August 2009 (C) 2009 Cancer Research UK
引用
收藏
页码:871 / 874
页数:4
相关论文
共 16 条
  • [1] Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden
    Andrae, Bengt
    Kemetli, Levent
    Sparen, Par
    Silfverdal, Lena
    Strander, Bjorn
    Ryd, Walter
    Dillner, Joakim
    Tornberg, Sven
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09): : 622 - 629
  • [2] Trends in cancer of the cervix uteri in Sweden following cytological screening
    Bergström, R
    Sparén, P
    Adami, HO
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (01) : 159 - 166
  • [3] Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands
    Bos, Anita B.
    Rebolj, Matejka
    Habbema, J. Dik F.
    van Ballegooijen, Marjolein
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) : 2372 - 2375
  • [4] Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women
    Forslund, O
    Antonsson, A
    Edlund, K
    van den Brule, AJC
    Hansson, BG
    Meijer, CJLM
    Ryd, W
    Strand, A
    Wadell, G
    Dillner, J
    Johansson, B
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (04) : 535 - 541
  • [5] Low efficiency of cytologic screening for cancer in situ of the cervix in older women
    Gustafsson, L
    Sparen, P
    Gustafsson, M
    Pettersson, B
    Wilander, E
    Bergstrom, R
    Adami, HO
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (06) : 804 - 809
  • [6] HUMAN PAPILLOMAVIRUSES IN THE PATHOGENESIS OF ANOGENITAL CANCER
    HAUSEN, HZ
    [J]. VIROLOGY, 1991, 184 (01) : 9 - 13
  • [7] Screening history of women in Malmo with invasive cervical cancer
    Lindqvist, Pelle G.
    Hellsten, Charlotte
    Rippe, Amanda
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 137 (01): : 77 - 83
  • [8] Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    Castle, Philip E.
    Hesselink, Albertus T.
    Franco, Eduardo L.
    Ronco, Guglielmo
    Arbyn, Marc
    Bosch, F. Xavier
    Cuzick, Jack
    Dillner, Joakim
    Heideman, Danielle A. M.
    Snijders, Peter J. F.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 516 - 520
  • [9] Human papillomavirus and papanicolaou tests to screen for cervical cancer
    Naucler, Pontus
    Ryd, Walter
    Tornberg, Sven
    Strand, Anders
    Wadell, Goran
    Elfgren, Kristina
    Radberg, Thomas
    Strander, Bjorn
    Forslund, Ola
    Hansson, Bengt-Goran
    Rylander, Eva
    Dillner, Joakim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16) : 1589 - 1597
  • [10] Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing?: A systematic review and meta-analysis
    Petignat, Patrick
    Faltin, Daniel L.
    Bruchim, Ilan
    Train, Martin R.
    Franco, Eduardo L.
    Coutlee, Francois
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 105 (02) : 530 - 535